What is the effect of everolimus in the treatment of breast cancer
Everolimus belongs to the mTOR inhibitor, which targets the preclinical activity of breast cancer cell lines. It is currently proven to be used for reversing Akt-induced resistance to hormones and trastuzumab. Everolimus can be used for advanced hormone receptor positive and HER-2 negative breast cancer patients after menopause. So, what is the effect of everolimus combined treatment of breast cancer? […]